World Allergy Organization's official journal to become open access

December 20, 2012

BioMed Central, the open access publisher, is pleased to announce the World Allergy Organization Journal (WAO Journal), the official journal of the World Allergy Organization (WAO), is moving to BioMed Central's open access publishing platform to join our growing open access allergy portfolio.

The prevalence of allergy and its impact on society continues to rise, therefore access to allergy research is paramount in order to achieve sustainable results towards future prevention, diagnosis and treatment. The growth of interest into allergic diseases is reflected in BioMed Central's collection of allergy journals and the transition by the WAO to open access.

The WAO is an international umbrella organization for the allergy community, whose members consist of 89 regional and national asthma, allergology and clinical immunology societies from around the world. WAO Journal's Editor in Chief Dr Lanny Rosenwasser states, "The journal has been fully online from the start, so this move to open access is a natural shift, allowing WAO members and other WAO Journal authors to disseminate their research in the burgeoning field of allergy more efficiently."

The journal is an important vehicle for the WAO to be able to ensure that research will reach not only WAO members, but the widest possible global audience.

This move is another step towards the aims and vision of the WAO journal: to provide a global forum for the exchange of research and information on allergy, asthma, and clinical immunology.

Dr Ruby Pawankar, President of the World Allergy Organization, said, "As an organization with global reach, it is important for our official journal to mirror the organization's commitments to improving the knowledge-share needed for immediate care and prevention of asthma and allergic disease, which are becoming more complex and more prevalent worldwide, especially in children, and increasing in the burden on patients as well as societies."

Beginning in January 2013, WAO Journal readers will have free, instant online access to all published articles not only on BioMed Central's website, but also on PubMed Central as well as other open access repositories, free from the constraints of print publication cycles.
-end-
Media Contact

Rebecca Fairbairn
Public Relations Manager, BioMed Central
Tel: +44 (0) 20 3192 2433
Mob: +44 (0) 7825 257423
Email: rebecca.fairbairn@biomedcentral.com

Notes to Editors

1. World Allergy Organization Journal (http://new.waojournal.org/b) publishes original research, clinical reviews, position papers, and epidemiological studies that contribute to current knowledge in patient care with authors, reviewers and readers representing all geographic regions, providing a truly global perspective on allergy, asthma and clinical immunology. WAO Journal is accepting submissions; please use the online submission system to submit your manuscript. For all enquiries about the journal, please contact: waoj@worldallergy.org and journals@biomedcentral.com or contact Sofia Dorsano Director, Publications, Education & Communications World Allergy Organization sdorsano@worldallergy.org.

2. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector. @BioMedCentral

BioMed Central

Related Asthma Articles from Brightsurf:

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

Researchers make asthma breakthrough
Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.

Physics vs. asthma
A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.

New knowledge on the development of asthma
Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.

Eating fish may help prevent asthma
A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.

Academic performance of urban children with asthma worse than peers without asthma
A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.

Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.

Asthma management tools improve asthma control and reduce hospital visits
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.

Asthma linked to infertility but not among women taking regular asthma preventers
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.

What are the best ways to diagnose and manage asthma?
A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.

Read More: Asthma News and Asthma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.